NewsRx

Search our medical news database

Oncology Business Week

Susan Hasty, Publisher

Table of Contents . . . June 5th, 2005

Non-Subscriber - Summaries Only

Related Areas: Other Issues in Oncology Business Week | Other Publications

Antisoma - Cancer drug developer drops AS1405 to accelerate AS1411

Avecia - Manufacturing agreement signed for ProMune

Celator Pharmaceuticals, Inc. - Biopharmaceutical firm closes $40M financing

Cell Genesys, Inc. - Synergistic antitumor activity reported for GVAX cancer vaccine

Conforma Therapeutics Corp. - Cancer therapeutics company completes final tranche of financing

Curis, Inc. - FDA accepts Genentech's application to start skin cancer treatment phase I trial

EntreMed, Inc. - Panzem maker reports Q1 net loss of $5.5 million

Exelixis, Inc. - Company files IND application for anticancer compound XL844

Genzyme Corporation - Hospital and cancer institute grant rights to develop diagnostic test

Immunicon Corporation - Diagnostics company reports loss of $0.30 per share

Incyte Corporation - Oncology drug maker reports loss of $0.24 per share

McMaster University - New prostate cancer studies look at hormone and protein connection

Miikana Therapeutics, Inc. - Biopharmaceutical company licenses phase II clinical anticancer compound

Novartis Oncology - New drug applications filed for treatment of blood transfusions iron overload

Onyx Pharmaceuticals, Inc. - All patients in phase III trial offered sorafenib for renal cell carcinoma

Academy Sinica, Taipei - Different techniques used for urinary protein analysis of lung cancer patients

Adventrx Pharmaceuticals, Inc. - Preliminary results for CoFactor phase II trial published

Agilent Technologies, Inc. - Deal signed for Glycomics Solution for proteomics research

Aichi Cancer Center - Intestinal metaplasia examined, endocrine cell co-existence described

American Academy of Dermatology - Boost vitamin D intake via nutrition, not sun, group says

American Academy of Dermatology - Group provides advice on avoiding skin cancer

American Academy of Dermatology - Skin cancer treatments focus on surgical approaches, new noninvasive therapies

AmpliMed - Amplimexon exhibits unique mechanisms of synergy with gemcitabine

Antisense Pharma GmbH - Patient recruitment completed for AP 12009 phase II trial

Antoni Van Leeuwenhoek Hospital, Amsterdam - Four different assays for the determination of serum S-100B compared

Ariad Pharmaceuticals, Inc. - IND filed with U.S. FDA to initiate trials of oral dosage form of AP23573

Asahikawa Medical College - Recent findings illuminate research in oncology

BioVisioN AG - ImVisioN sold to Nextech Venture, L.P.

Biomarker Technologies LLC - Makers of new blood test for breast cancer seeks future test candidates

Boston Medical Center - Nonsteroidal anti-inflammatory drugs for colorectal cancer prevention advised

Buck Institute for Age Research, Novato - NF kappa B activation identifies high-risk subset of ER-dependent cancers

Celera Genomics - Genomics company files IND application for HDAC inhibitor, CRA-024781

Central Brain Tumor Registry, Hinsdale - Consensus Conference discussed cancer registration of brain and CNS tumors

Centre Hospitalier Universitaire, Nancy - Cost-effectiveness of FDG-PET in lung cancer diagnostics analyzed

Chiang Mai University - P-glycoprotein function and expression inhibited by kaempferol and quercetin

Chiba National Cancer Center - Hyaluronan synthase expression marked pleural malignant mesotheliomas

Chiba University Hospital - Hormonal traits predict how well prostate cancer will respond to therapy

Chinese Academy of Sciences, Shanghai -  Shiraia bambusicola derivative is a potent angiogenesis inhibitor

Chinese Academy of Sciences, Shanghai - Dual gene-virotherapy eradicates established tumors in animal models

Chinese People's Liberation Army General Hospital - Benign hyperplasia in the prostatic outer gland confused with prostate cancer

Chinese University of Hong Kong - Promoter hypermethylation of RASSF1A and MGMT linked with clinical implications

Chungtai Institute of Health Science, Taichung - Increased levels of urokinase plasminogen activator implicated in lung cancer

Colorado State University, Fort Collins - Refeeding after chronic dietary energy restriction reverses anticancer effect

Correlogic Systems, Inc. - Development of prostate cancer blood tests to move forward

Cutting Edge Information - Report shows pharma companies spend $76.8 million launching cancer treatments

Deutsch Krebsforschungszentrum, Heidelberg - Reports describe recent advances in leukemia research

DiagnoCure, Inc. - Cancer detection-focused company appoints CFO

Dresden University of Technology - HLA-DRB1* 01 genotype increases risk for adrenocortical carcinoma

Early Breast Cancer Trialists' Collaborative Group - Substantial 15-year survival gains from standard treatments

Emory University Hospital, Atlanta - LANA sensitive/specific KS marker in general and HIV-infected populations

Emory University, Atlanta - Interferon alfa-2a, isotretinoin, and vitamin E involved in phase 2 study

Endocyte, Inc. - Cancer/autoimmune-focused company moves operations to Purdue Technology Center

Evangelico Valdese Hospital, Turin - Fine-needle aspiration should be first step in assessing suspicious lymph nodes

G. Gaslini Children's Hospital, Genoa - Central venous catheter-related complications characterized

German Cancer Research Center DKFZ, Heidelberg - ERBB2 variant Ile654Val associated with increased familial breast cancer risk

Grant Life Sciences - Clinical trials of blood test for HPV-associated cervical cancer are underway

Harvard University - Local enucleation relieved symptoms in patients with esophageal leiomyoma

Harvard University - Researchers consider possible mechanistic links between obesity and asthma

Hokkaido University - Aberrant HOX gene expression related to breast cancer development

Hospital Calmette, Lille - RT-PCR is an early predictive factor of relapse risk in AML with t(8; 21)

Hospital La Fe, Valencia - Anterior chamber infiltrated in patient with Ph+ acute lymphoblastic leukemia

Hospital for Special Surgery, New York - How normal B cells become leukemic cells

IMI International Medical Innovations - Pivotal breast cancer study launched

INSERM U540 - Aromatase expression detected in some ovarian epithelial cancer cells, tissues

Indiana University - Esophageal cancer patients treated with neoadjuvant chemoradiation reviewed

Indiana University - Telomere dysfunction involved in aging and cancer

Information Technology - Impac to offer specimen tracking using barcoding technology

Institut Curie, Paris - One-thousandth patient treated with BEBIG seeds

Institute Gustave Roussy, Villejuif - Surgical treatment of peritoneal carcinomatosis examined

Institute of Cancer Research, London - Chemotherapy augments gene therapy targeting tumor vessels

Institute of Oncology, Ljubljana - Findings advance knowledge in breast cancer research

Int'l Center for Genetics Eng & Bio., Trieste - New findings in the area of cancer vaccines detailed

Kanazawa University - COX-2 inhibitor prevents esophageal inflammation-metaplasia-adenocarcinoma

Kanazawa University - Hematopoietic cells regulate angiogenic switch during tumorigenesis

Kangbuk Samsung Hospital - OcculTech fecal occult blood test suitable for colorectal neoplasia screening

Karolinska Hospital, Stockholm - Distribution of cutaneous squamous cell carcinoma in organ transplant recipients

Karolinska Institute - Tobacco smoking and snuff dipping implicated in risk of squamous cell carcinoma

Karolinska University Hospital, Stockholm - Cyclin B1 predicts favorable outcomes in patients with follicular lymphoma

Keio University, Tokyo - Microsatellite instability in inflamed mucosa helped predict colonic neoplasms

Kyoto University - Cisplatin/adriamycin release from hydrogel has synergistic antitumor effects

Kyung Hee University Hospital, Seoul - Factors raise cancer risk in those with current and past HBV infections

Leiden University - Cancer immunotherapy targets minor histocompatibility antigens

Return to Top of Page

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook